Nutranomics, a food supplement company based in Draper, USA had announced the official launch of Glucozyme, a nutritional supplement to assist in the reduction of blood glucose levels in patients with type 2 diabetes. The Company will offer Glucozyme for sale; direct to consumers and distributors through its e-commerce website beginning from December 1st, 2013.
“Following the successful completion of three separate studies on Glucozyme regarding the reduction of blood sugar levels, we are very confident that this product is ready for distribution throughout the U.S. and Japanese markets,” stated Nutranomics CEO, Dr Tracy K Gibbs. “Though legally we cannot make any medical claims regarding the treatment of disease with Glucozyme, I strongly believe that diseases such as heart disease, diabetes, and many others are diet and lifestyle related and that high quality dietary supplements can play an important role in providing positive outcomes for people and their families.”
Three separate studies conducted on Glucozyme regarding the reduction of blood sugar levels were unanimously positive. The three studies measured both the fasting glucose levels and the HbA1-c levels of Type 2 diabetics for 30, 60, and 90 days. The results of each study showed that Glucozyme reduced blood sugar levels and HbA1-c levels in patients by 22-28% within the study period.
Dr Gibbs concluded, “A lot of hard work and brain power from the entire Nutranomics team has gone into the development and testing of Glucozyme, so I’m extremely pleased that it has become a potential breakthrough product for us in 2014. I look forward to discussing the Glucozyme study results and distribution opportunities with our current and potential new customers in the USA and particularly in Asia during the coming weeks.”